Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide as a First-line Treatment in Naïve Patients With HIV-1 Infection With Severe Immunosuppression [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a single-tablet regimen (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide) as first-line therapy in treatment-naïve adults w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Elvitegravir / Cobicistat / Emtricitabine / Tenofovir Alafenamide (E/C/F/TAF)

Snippet

Sponsor: Fundacion SEIMC-GESIDA | Conditions: HIV Infections, Severe Immunosuppression | Phase 4 | Status: COMPLETED